Concepedia

Martin Zweifel

MZ

22

Publications

1K

Citations

17

H-Index

2002

Active since

Affiliations

University Hospital of Bern(Current)

Mount Vernon Cancer Centre

University Hospital of Zurich

University of Bern

Churchill Hospital

Martin Zweifel is an author at University Hospital of Bern specializing in medicine, immunology, and radiation oncology.

Top concepts

Publications per year

2002–2017

22

Publications

22

Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer

Paul Nathan, Martin Zweifel, Anwar R. Padhani et al. · Clinical Cancer Research · 2012 · 168 citations

Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer

Martin Zweifel, Gordon C. Jayson, N.S. Reed et al. · Annals of Oncology · 2011 · 158 citations

, , +8

A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer

Gordon Rustin, Gavin Shreeves, Paul Nathan et al. · British Journal of Cancer · 2010 · 130 citations · Full text

Phase I Clinical and Pharmacokinetic Evaluation of the Vascular-Disrupting Agent OXi4503 in Patients with Advanced Solid Tumors

Dan M. Patterson, Martin Zweifel, Mark R. Middleton et al. · Clinical Cancer Research · 2012 · 73 citations

Treatment of POEMS syndrome with bevacizumab

Panagiotis Samaras, S. Bauer, Frank Stenner et al. · Haematologica · 2007 · 69 citations · Full text

, , +13

Rows per page

1–5 of 22